Levetiracetam Solution
NDC Package 65862-250-47
Package Information
Levetiracetam solution is levetiracetam is used to treat seizures (epilepsy). This formulation utilizes a solution delivery system. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 65862-250 and is authorized under FDA application ANDA079063.
Identification & Billing
- RxCUI: 403884 - levETIRAcetam 100 MG in 1 mL Oral Solution
- RxCUI: 403884 - levetiracetam 100 MG/ML Oral Solution
- RxCUI: 403884 - levetiracetam 100 MG per 1 ML Oral Solution
- RxCUI: 403884 - levetiracetam 1000 MG per 10 ML Oral Solution
- RxCUI: 403884 - levetiracetam 1500 MG per 15 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65862 - Aurobindo Pharma Limited
- 65862-250 - Levetiracetam
- 65862-250-47 - 473 mL in 1 BOTTLE, PLASTIC
- 65862-250 - Levetiracetam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65862-250). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65862-250-47 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Levetiracetam, a human prescription drug labeled by Aurobindo Pharma Limited. This solution is formulated for oral use and contains levetiracetam as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurobindo Pharma Limited on January 15, 2009. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.
How is this Aurobindo Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65862025047. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.